Genomic mechanisms of disease progression in pediatric medullary thyroid cancer (MTC)

被引：0
|
作者：
Kraft, Ira L.
Akshintala, Srivandana
Killian, Keith J.
Hufnagel, Robert B.
Glod, John W.
Derse-Anthony, Claudia
Zhu, Yuelin
Stevenson, Holly S.
Bradford, Diana
Merino, Maria J.
Balis, Frank M.
Fox, Elizabeth
Widemann, Brigitte C.
Shern, Jack F.
Meltzer, Paul S.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4882
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4882
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Recurrent medullary or mixed papillary and medullary thyroid cancer identified by 99mTc-Depreotide; correlation with tumor markers
    Valsamaki, P.
    Gotzamani-Psarrakou, A.
    Molyvda, E.
    Papantoniou, V.
    Tzitzikas, I.
    Zanglis, A.
    Fountos, G.
    Gerali, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S361 - S361
  • [42] Influence of lymph node metastases on survival in pediatric medullary thyroid cancer
    Raval, Mehul V.
    Sturgeon, Cord
    Bentrem, David J.
    Elaraj, Dina M.
    Stewart, Andrew K.
    Winchester, David J.
    Ko, Clifford Y.
    Reynolds, Marleta
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (10) : 1947 - 1954
  • [43] Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer
    Ji, Jun Ho
    Oh, Young Lyun
    Hong, Mineui
    Yun, Jae Won
    Lee, Hyun-Woo
    Kim, DeokGeun
    Ji, Yongick
    Kim, Duk-Hwan
    Park, Woong-Yang
    Shin, Hyun-Tae
    Kim, Kyoung-Mee
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    PLOS GENETICS, 2015, 11 (08):
  • [44] Medullary thyroid carcinoma: the influence of policy changing in clinical characteristics and disease progression
    Alevizaki, Maria
    Saltiki, Katerina
    Rentziou, Gianna
    Papathoma, Alexandra
    Sarika, Leda
    Vasileiou, Vasiliki
    Anastasiou, Eleni
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (06) : 799 - 808
  • [45] Depression and cancer: Mechanisms and disease progression
    Spiegel, D
    Giese-Davis, J
    BIOLOGICAL PSYCHIATRY, 2003, 54 (03) : 269 - 282
  • [46] Response to "Long-term outcome of 'prophylactic therapy' for familial medullary thyroid cancer (MTC)"
    Sadacharan, Dhalapathy
    Agarwal, Gaurav
    SURGERY, 2011, 149 (06) : 851 - 851
  • [47] SAFETY AND EFFICACY OF VANDETANIB AS SYSTEMIC TREATMENT FOR PATIENTS WITH ADVANCED AND PROGRESSIVE MEDULLARY THYROID CANCER (MTC)
    Grande, E.
    Martinez-Trufero, J.
    Arevalo, S.
    Alvarez-Escola, C.
    Beltran, M.
    Jimenez Fonseca, P.
    Alonso-Gordoa, T.
    Dalmau, E.
    Duran, M.
    Gallegos, I.
    Manzano, J. L.
    Mesia, R.
    Pajares, I.
    Fuentes, J.
    Grau, J. J.
    Reig Torras, O.
    Trigo, J. M.
    Pelaez, B.
    Zafon, C.
    Capdevila, J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [48] METAIODOBENZYLGUANIDINE UPTAKE IN MEDULLARY-THYROID CANCER (MTC) - A FEATURE OF MULTIPLE ENDOCRINE NEOPLASIA (MEN)
    BAULIEU, JL
    GUILLOTEAU, D
    CALMETTE, C
    COUTRIS, G
    DELISLE, MJ
    GARDET, D
    BAULIEU, F
    DELEPINE, N
    ITTI, R
    POURCELOT, L
    BESNARD, JC
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1009 - 1009
  • [49] Cholecystokinin-B/gastrin receptor scintigraphy for the staging of metastatic medullary thyroid cancer (MTC).
    Behr, TM
    Behe, M
    Gratz, S
    Hüfner, M
    Becker, W
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 98P - 98P
  • [50] Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC)
    Shah, M.
    Sherman, E.
    Robinson, B.
    Solomon, B.
    Kang, H.
    Lorch, J.
    Worden, F.
    Brose, M.
    Leboulleux, S.
    Godbert, Y.
    Meurer, M.
    Morris, J.
    Owonikoko, T.
    Tan, D. S. -W.
    Gautschi, O.
    Patel, J.
    Yang, L.
    Kherani, J.
    Cabanillas, M.
    Wirth, L.
    Weiler, D.
    SWISS MEDICAL WEEKLY, 2020, : 7S - 8S
12345